While Group 1 markers are mostly equivalent to classical CIMP markers 11, 12, 35, 36, HME/CIMP‐high CRC shows methylation of both Group 1 and Group 2 markers, and strongly correlate with BRAF‐mutation(+). This evidence concerns the gene BRAF and colorectal carcinoma.